Plasmonix to launch QuantArray, which detects microscopic cells for research

Plasmonix, the bioanalysis technology company that was one of the first companies to receive a (small) piece of the $84 million InvestMaryland fund, plans to launch its first product early this year, reports BmoreMedia.
The product, QuantArray, “has various applications in performing assays, a test that analyzes components, and enhances luminescent signals hundred-fold over conventional methods,” according to BmoreMedia.
At the heart of Plasmonix’s business is metal-enhanced fluorescence, which is a process used to detect cells in medical and clinical research. The technology behind Plasmonix’s business has applications not only in the medical field, but also in cosmetics, paints and lighting.
Founded in 2009, Plasmonix occupies space in UMBC‘s Research and Technology Park, and has four employees now.